Kyle Bauser, ROTH Capital Partners, LLC, Research Division: Asked about 2026 revenue mix and initial MAGiC feedback. Fischel reported most revenue growth will come from disposables as manufacturing ...

Longer transfer door-in-door-out times for endovascular therapy in AIS are associated with worse functional outcomes and complications.

Stereotaxis (NYSEAMERICAN:STXS) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight a ...

Ace Therapeutics, a leading provider of preclinical contract research services for stroke drug development, is advancing the discovery and development of novel stroke therapeutics by offering ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

(Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that Tampa General Hospital has become the first health system in Florida to adopt ...

Across hospitals and health systems, stroke care sits at the intersection of several pressures leaders know well: rising acuity, uneven access to specialty care, workforce constraints and growing ...

Mordor Intelligence has published a new report on critical ischemia treatment market offering a comprehensive analysis of trends, growth drivers, and future projections.

Dr. Ganni Bhaskara Rao’s journey proves that world-class healthcare is not the prerogative of the metropolis alone. By ...

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

Excited for NASA's Artemis II launch? The best model rockets mean you can have your own rocket launch, as scale replicas and STEM kits all feature. When you purchase through links on our site, we may ...

The peripheral vascular device market will rise from $10.4B in 2025 to $14.8B by 2032, driven by drug‑coated balloons, ...